Holen Sie sich die Stockscreener-App
26.19
7.03%
-1.98
Handel nachbörslich:
26.18
-0.01
-0.04%
Schlusskurs vom Vortag:
$28.17
Offen:
$28.17
24-Stunden-Volumen:
412.20K
Relative Volume:
1.20
Marktkapitalisierung:
$980.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-5.45%
1M Leistung:
+32.34%
6M Leistung:
+144.54%
1J Leistung:
-3.68%
1-Tages-Spanne:
$25.84
$28.17
1-Wochen-Bereich:
$25.84
$29.46
52-Wochen-Spanne:
$5.485
$29.46
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Firmenname
Oruka Therapeutics Inc
Sektor
Branche
Telefon
650-606-7910
Adresse
855 OAK GROVE AVE., MENLO PARK
Vergleichen Sie ORKA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
26.19 | 1.36B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-27 | Eingeleitet | Guggenheim | Buy |
| 2025-10-13 | Eingeleitet | Barclays | Overweight |
| 2025-05-22 | Eingeleitet | BTIG Research | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-11 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-09-16 | Eingeleitet | TD Cowen | Buy |
| 2024-09-13 | Eingeleitet | Jefferies | Buy |
| 2018-02-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2013-10-09 | Eingeleitet | Dawson James | Buy |
Alle ansehen
Oruka Therapeutics Inc Aktie (ORKA) Neueste Nachrichten
Is Oruka Therapeutics Inc. (HQ1) stock a momentum leaderQuarterly Earnings Summary & Reliable Price Breakout Signals - newser.com
What technical charts say about Oruka Therapeutics Inc. stockJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
How Oruka Therapeutics Inc. (HQ1) stock behaves in tightening cyclesJuly 2025 Breakouts & Free Community Consensus Stock Picks - newser.com
Is Oruka Therapeutics Inc. (HQ1) stock undervalued at current priceJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Can Oruka Therapeutics Inc. stock sustain market leadershipWeekly Stock Report & Smart Swing Trading Techniques - newser.com
Tools to monitor Oruka Therapeutics Inc. recovery probabilitySwing Trade & Expert Curated Trade Setups - newser.com
Why retail investors favor Oruka Therapeutics Inc. stockForecast Cut & Capital Efficient Trade Techniques - newser.com
Can Oruka Therapeutics Inc. (HQ1) stock hold up in economic slowdown2025 Dividend Review & Free High Accuracy Swing Entry Alerts - newser.com
What valuation ratios show for Oruka Therapeutics Inc. (HQ1) stockJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
Why Oruka Therapeutics Inc. stock attracts global investorsDollar Strength & Free High Accuracy Swing Entry Alerts - newser.com
Will Oruka Therapeutics Inc. stock recover faster than market2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com
Is Oruka Therapeutics Inc. stock supported by strong cash flowsMarket Sentiment Report & Weekly Sector Rotation Insights - newser.com
Is Oruka Therapeutics Inc. stock a bargain at current levelsIPO Watch & Weekly Chart Analysis and Trade Guides - newser.com
Key metrics from Oruka Therapeutics Inc.’s quarterly data2025 Top Gainers & Fast Entry Momentum Alerts - newser.com
Volume spikes in Oruka Therapeutics Inc. stock – what they meanFed Meeting & Safe Capital Allocation Plans - newser.com
Will Oruka Therapeutics Inc. (HQ1) stock return to pre crash levels2025 Support & Resistance & Safe Entry Zone Tips - newser.com
What technical patterns form on Oruka Therapeutics Inc. (HQ1) stock chartsPortfolio Risk Summary & AI Powered Market Trend Analysis - newser.com
Will Oruka Therapeutics Inc. stock outperform growth indexes2025 Sector Review & AI Based Buy/Sell Signal Reports - newser.com
What analysts say about Oruka Therapeutics Inc stockCovered Call Writing & Control Your Emotions With Discipline Tools - earlytimes.in
Published on: 2025-10-31 04:52:14 - newser.com
Price action breakdown for Oruka Therapeutics Inc.Insider Buying & Verified Entry Point Detection - newser.com
Pattern recognition hints at Oruka Therapeutics Inc. upside2025 Historical Comparison & Reliable Volume Spike Alerts - newser.com
Will Oruka Therapeutics Inc. stock go up soonGap Down & Entry and Exit Point Strategies - newser.com
Oruka Therapeutics’ Promising Psoriasis Study: What Investors Need to Know - MSN
HC Wainwright Brokers Raise Earnings Estimates for ORKA - MarketBeat
Q3 EPS Forecast for Oruka Therapeutics Boosted by Analyst - Defense World
Published on: 2025-10-29 21:32:46 - newser.com
Wall Street Analysts Predict a 63.59% Upside in Oruka Therapeutics, Inc. (ORKA): Here's What You Should Know - sharewise.com
Finanzdaten der Oruka Therapeutics Inc-Aktie (ORKA)
Es liegen keine Finanzdaten für Oruka Therapeutics Inc (ORKA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):